Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistanceCamille Duluc, Corinne Bousquet, Siham Moatassim-Billah et al.|EMBO Molecular Medicine|2015Cited by 196
Anti-oncogenic potential of the eIF4E-binding proteinsYvan Martineau, Stéphane Pyronnet, R Azar et al.|Oncogene|2012Cited by 109
FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancerSonia Zaghdoudi, Christine Jean, Emilie Decaup et al.|EMBO Molecular Medicine|2020Cited by 105
Pancreatic tumours escape from translational control through 4E-BP1 lossYvan Martineau, Stéphane Pyronnet, R Azar et al.|Oncogene|2013Cited by 67
eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancerDavid C. Muller, Yvan Martineau, Sauyeun Shin et al.|JCI Insight|2019Cited by 48